In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

The HEART path, Help with Adaptation and Rehabilitation Trajectory

Session Poster Session 2

Speaker Caroline Wulffraat

Event : Heart Failure 2019

  • Topic : cardiovascular nursing and allied professions
  • Sub-topic : Cardiovascular Nursing and Allied Professions - Other
  • Session type : Poster Session

Authors : C J Wulffraat (capelle aan den ijssel,NL), AC Hofman-Tanis (capelle aan den ijssel,NL)

Authors:
C J Wulffraat1 , AC Hofman-Tanis1 , 1ijsselland ziekenhuis - capelle aan den ijssel - Netherlands (The) ,

Citation:

Context
In the Netherlands today, there is a growing group of elderly patients with cardiac diseases who will not undergo cardiac surgical intervention. Cardiac surgery can technically be performed in fragile, older patients, but it is difficult for the individual patient to weigh the risks and benefits of such major surgery.  A palliative approach is needed from the moment of deciding that there will be no intervention, since these patients are then confronted with a life limiting disease. Knowledge and cooperation from multi-disciplinary care professionals, who are involved in care for this patient category, is needed to develop a care pathway that supports these patients in adapting to a life limiting disease.
Method
The method of action research was chosen. Eleven patients, and one relative, with this specific cardiac condition were interviewed (semi structured). Two multidisciplinary heart teams gave input through patient assessments.  Focus sessions with local cardiologists, NP's, GP’s and homecare nurses provided a multi-faceted view on the concept of the care pathway. A care pathway was designed and implemented. Before discharge there is a shared decision on the treatment plan. Weekly home visits from a heart failure nurse with expertise in symptom recognition and relief are planned in the first month after discharge. This includes advanced care planning and, if necessary, continuing visits. A digital two-way patient file provides communication between home care and the heart failure clinic. At discharge the GP is informed by telephone and on paper and a home visit is planned.
Findings
At the time of the shared decision-making, patients rate honesty and expertise the highest. The cardiologists use hard data for decision-making, however, the widely used EuroSCORE does not cover this patient category. At discharge there was poor communication between care professionals, particularly with regards to symptom recognition and relief. Symptoms such as tiredness, fluid retention and weakness are experienced daily. There is a fear of acute, severe symptoms that often return at night, such as dyspnoea, chest pain and the feeling of suffocating/ dying. In the first 18 months 83 patients were included in the pathway, 23 improved, 28 still have regular visits. Communication via the digital two way patient file is highly valued. Furthermore 32 patients died, 22 at home, 4 in a hospice and 4 in hospital,  2 places of death are still unclear. Re-admission data and data on symptom relief is currently being assessed.
Conclusions
Inclusion of frailty scores such as ISAR and KATZ ADL can provide a better patient assessment. Poor communication at discharge leads to inadequate symptom recognition and relief. The loss of mobility, due to symptoms and unpredictability of the disease and fear of returning symptoms can be addressed by a palliative approach. Since the start of the care pathway only 12,5% of the included patients died in hospital.

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are